ConductScience.org, home

Trial · NCT01229436

Results by group631

Each measurement the trial posted, group by group, in the words and numbers it posted.

OutcomeGroupCategoryValueSpreadUnits
Total Passive Extension Deficit (TPED) at Baseline for First InjectionXiapex55.0Full Range 2 to 180degrees
Passive Extension Deficit (PED) for Metacarpophalangeal (MP) and Proximal Interphalangeal (PIP) JointsXiapexBaseline for first injection: MP Joint (n=211)40.0Full Range 0 to 90degrees
Passive Extension Deficit (PED) for Metacarpophalangeal (MP) and Proximal Interphalangeal (PIP) JointsXiapexDay 1 after first injection: MP Joint (n=207)8.0Full Range 0 to 80degrees
Passive Extension Deficit (PED) for Metacarpophalangeal (MP) and Proximal Interphalangeal (PIP) JointsXiapexDay 7 after first injection: MP Joint (n=209)0.0Full Range 0 to 82degrees
Passive Extension Deficit (PED) for Metacarpophalangeal (MP) and Proximal Interphalangeal (PIP) JointsXiapexDay 30 after first injection: MP Joint (n=209)0.0Full Range 0 to 70degrees
Passive Extension Deficit (PED) for Metacarpophalangeal (MP) and Proximal Interphalangeal (PIP) JointsXiapexBaseline for second injection: MP Joint (n=33)25.0Full Range 0 to 74degrees
Passive Extension Deficit (PED) for Metacarpophalangeal (MP) and Proximal Interphalangeal (PIP) JointsXiapexDay 1 after second injection: MP Joint (n=33)5.0Full Range 0 to 45degrees
Passive Extension Deficit (PED) for Metacarpophalangeal (MP) and Proximal Interphalangeal (PIP) JointsXiapexDay 7 after second injection: MP Joint (n=33)5.0Full Range 0 to 50degrees
Passive Extension Deficit (PED) for Metacarpophalangeal (MP) and Proximal Interphalangeal (PIP) JointsXiapexDay 30 after second injection: MP Joint (n=32)8.5Full Range 0 to 30degrees
Passive Extension Deficit (PED) for Metacarpophalangeal (MP) and Proximal Interphalangeal (PIP) JointsXiapexBaseline for third injection: MP Joint (n=9)20.0Full Range 0 to 50degrees
Passive Extension Deficit (PED) for Metacarpophalangeal (MP) and Proximal Interphalangeal (PIP) JointsXiapexDay 1 after third injection: MP Joint (n=9)0.0Full Range 0 to 50degrees
Passive Extension Deficit (PED) for Metacarpophalangeal (MP) and Proximal Interphalangeal (PIP) JointsXiapexDay 7 after third injection: MP Joint (n=9)10.0Full Range 0 to 40degrees
Passive Extension Deficit (PED) for Metacarpophalangeal (MP) and Proximal Interphalangeal (PIP) JointsXiapexDay 30 after third injection: MP Joint (n=9)20.0Full Range 0 to 40degrees
Passive Extension Deficit (PED) for Metacarpophalangeal (MP) and Proximal Interphalangeal (PIP) JointsXiapexBaseline for follow-up: MP Joint (n=201)40.0Full Range 0 to 90degrees
Passive Extension Deficit (PED) for Metacarpophalangeal (MP) and Proximal Interphalangeal (PIP) JointsXiapexFollow-up Day 90: MP Joint (n=201)0.0Full Range 0 to 70degrees
Passive Extension Deficit (PED) for Metacarpophalangeal (MP) and Proximal Interphalangeal (PIP) JointsXiapexFollow-up Day 180: MP Joint (n=207)0.0Full Range 0 to 85degrees
Passive Extension Deficit (PED) for Metacarpophalangeal (MP) and Proximal Interphalangeal (PIP) JointsXiapexBaseline for first injection: PIP Joint (n=98)45.0Full Range 15 to 94degrees
Passive Extension Deficit (PED) for Metacarpophalangeal (MP) and Proximal Interphalangeal (PIP) JointsXiapexDay 1 after first injection: PIP Joint (n=98)20.0Full Range 0 to 80degrees
Passive Extension Deficit (PED) for Metacarpophalangeal (MP) and Proximal Interphalangeal (PIP) JointsXiapexDay 7 after first injection: PIP Joint (n=97)14.0Full Range 0 to 90degrees
Passive Extension Deficit (PED) for Metacarpophalangeal (MP) and Proximal Interphalangeal (PIP) JointsXiapexDay 30 after first injection: PIP Joint (n=98)18.5Full Range 0 to 90degrees

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT01229436/results